Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 31

Trial Status

Completed1
Terminated1
Other1

Role Distribution

Principal Investigator2
Other Roles1
PI Rate67%

Activity Timeline

Clinical Trials (3)

NCT01982448Phase 2Completed
Cisplatin vs Paclitaxel for Triple Negative Breast Cancer
Triple Negative Breast Cancer
Principalinvestigator
NCT02513394Phase 3Active Not Recruiting
PALbociclib CoLlaborative Adjuvant Study
Breast Cancer
Principalinvestigator

Research Network

Collaboration Network

12 collaborators·14 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Dana-Farber Cancer Institute

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00925652Phase 2StudyChair

Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast Cancer

Breast Cancer
Terminated
NCT01982448Phase 2PrincipalInvestigator

Cisplatin vs Paclitaxel for Triple Negative Breast Cancer

Triple Negative Breast Cancer
Completed
NCT02513394Phase 3PrincipalInvestigator

PALbociclib CoLlaborative Adjuvant Study

Breast Cancer
Active Not Recruiting

All 3 trials loaded